Macromoltek Inc

About:

Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics.

Website: https://www.macromoltek.com/

Twitter/X: Macromoltek

Top Investors: National Science Foundation, Y Combinator, Neotribe Ventures, DCVC Bio

Description:

Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics. This mother-daughter team’s approach aims to make research for everything from flu to cancer treatments an order of magnitude faster. With an accelerated process to discover antibodies, medical researchers can (1) craft targeted treatment plans for previously undruggable targets and (2) overcome patients’ drug resistance, a major challenge when treating diseases caused by bacteria, viruses, and parasites.

Total Funding Amount:

$1.49M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2010-01-01

Founders:

Monica Berrondo, Susana Kaufmann

Number of Employees:

11-50

Last Funding Date:

2018-03-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai